Sinil Pharmaceutical Co. Ltd (012790) — Free Cash Flow Generation Index
Sinil Pharmaceutical Co. Ltd (012790) has a Free Cash Flow Generation Index of 0.92x as of September 2025. Free cash flow of ₩2.41 Billion represents 1% of operating cash flow (₩2.62 Billion). See Sinil Pharmaceutical Co. Ltd (012790) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Sinil Pharmaceutical Co. Ltd Free Cash Flow Generation Index (2014–2024)
Historical FCF Generation Index trend for Sinil Pharmaceutical Co. Ltd across 11 annual periods. Explore Sinil Pharmaceutical Co. Ltd cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for Sinil Pharmaceutical Co. Ltd (2014–2024)
Year-by-year Free Cash Flow Generation Index for Sinil Pharmaceutical Co. Ltd. For the full company profile including market capitalisation, see 012790 market cap.
| Year | FCG Index | Free Cash Flow (KRW) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.63x | ₩14.22 Billion | ₩22.69 Billion | ₩8.47 Billion | ▲ +325.2% |
| 2023 | 0.15x | ₩2.23 Billion | ₩15.15 Billion | ₩12.92 Billion | ▼ -53.7% |
| 2022 | 0.32x | ₩4.36 Billion | ₩13.69 Billion | ₩9.33 Billion | ▼ -52.8% |
| 2021 | 0.67x | ₩7.53 Billion | ₩11.16 Billion | ₩3.63 Billion | ▲ +188.2% |
| 2020 | 0.23x | ₩2.59 Billion | ₩11.06 Billion | ₩8.80 Billion | ▼ -66.6% |
| 2019 | 0.70x | ₩8.63 Billion | ₩12.31 Billion | ₩9.73 Billion | ▼ -63.2% |
| 2018 | 1.91x | ₩17.53 Billion | ₩9.19 Billion | ₩8.33 Billion | ▼ -8.4% |
| 2017 | 2.08x | ₩18.05 Billion | ₩8.67 Billion | ₩9.38 Billion | ▲ +71.7% |
| 2016 | 1.21x | ₩14.66 Billion | ₩12.09 Billion | ₩2.57 Billion | ▼ -24.5% |
| 2015 | 1.61x | ₩15.37 Billion | ₩9.56 Billion | ₩5.80 Billion | ▲ +29.6% |
| 2014 | 1.24x | ₩11.57 Billion | ₩9.33 Billion | ₩2.24 Billion | — |